Buscar resultados de ensayos clínicos
Cystadenocarcinoma - 74 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Non Ivasive Prenatal Diagnosis (NIPD) of Cystic Fibrosis Condición: Noninvasive Mucinous Cystadenocarcinoma of Ovary Fecha: 2014-04-22 Intervenciones: Other: A sampling of blood A sampling of blood de 14 ml |
Completed |
Nombre del estudio: Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer Condición:
|
Active, not recruiting |
Nombre del estudio: Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer Condición:
|
Terminated |
Nombre del estudio: Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm Condición:
Intervenciones: Drug: Ethanol and Paclitaxel Injection Endoscopic ultrasound will be used to locate and assess the pancr |
Not yet recruiting |
Nombre del estudio: Proof-of-concept Study of Birinapant in Combination With Platinum Based Chemotherapy in Subjects With High Grade Serous Carcinomas Condición: Advanced Newly Diagnosed or Recurrent High Grade Serous Carcinomas (HGSC) Fecha: 2016-04-22 Intervenciones:
|
Recruiting |
Nombre del estudio: A Phase II Evaluation of Afatinibin Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma Condición: HER2/Neu+ Uterine Serous Carcinoma Fecha: 2015-07-02 Intervenciones: Drug: Afatinib Afatinib, 40 mg orally once daily on a 21 day cycle for the first 12 weeks, then every 28 |
Recruiting |
Nombre del estudio: Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage Condición:
Intervenciones: |
Completed |
Nombre del estudio: Edrecolomab in Treating Patients With Stage II Colon Cancer Condición:
|
Withdrawn |
Nombre del estudio: Research Study in Patients With Advanced Ovarian Epithelial Cancer Condición:
|
Recruiting |
Nombre del estudio: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condición:
|